Y'S AC

Establishment of company was settled on 8th of October,2010 as an independent company from Y'sTherapeutics Co., Ltd., with an aim to develop the cancer therapy by a humanized monoclonal antibody against CD26 molecule(YS110) which is expressing on a cell surface of tumor tissues and to investigate and develop new biological substances for the treatment of immune disorders and malignancies... A science-based company with the sole mission of alleviating human suffering through our products, YSAC aims to develop the cancer therapy by a humanized monoclonal antibody against CD26 molecule(YS110) which is expressing on a cell surface of tumor tissues and to investigate and develop new biological substances for the treatment of immune disorders and malignancies.

Also known as: Y's AC Co., Y's AC Co.,Ltd

Primary location: Tokyo Japan